97 related articles for article (PubMed ID: 19781916)
1. Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice.
Lin EJ; Lin S; Aljanova A; During MJ; Herzog H
Eur Neuropsychopharmacol; 2010 Mar; 20(3):164-75. PubMed ID: 19781916
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice.
Olesen MV; Christiansen SH; Gøtzsche CR; Nikitidou L; Kokaia M; Woldbye DP
J Neurosci Res; 2012 Feb; 90(2):498-507. PubMed ID: 21971867
[TBL] [Abstract][Full Text] [Related]
3. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.
Christiansen SH; Olesen MV; Gøtzsche CR; Woldbye DP
Neuropeptides; 2014 Dec; 48(6):335-44. PubMed ID: 25267070
[TBL] [Abstract][Full Text] [Related]
5. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
7. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
8. Behavioural profile of a new mouse model for NPY deficiency.
Karl T; Duffy L; Herzog H
Eur J Neurosci; 2008 Jul; 28(1):173-80. PubMed ID: 18616565
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice.
Karlsson RM; Holmes A; Heilig M; Crawley JN
Pharmacol Biochem Behav; 2005 Mar; 80(3):427-36. PubMed ID: 15740785
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
11. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and neuropeptide Y (intra-lateral septal) reduce anxiety-like behavior in two animal models of anxiety.
Olivera-Lopez JI; Molina-Hernández M; Tellez-Alcántara NP; Jaramillo MT
Peptides; 2008 Aug; 29(8):1396-403. PubMed ID: 18499302
[TBL] [Abstract][Full Text] [Related]
13. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.
Ruohonen ST; Savontaus E; Rinne P; Rosmaninho-Salgado J; Cavadas C; Ruskoaho H; Koulu M; Pesonen U
Neuroendocrinology; 2009; 89(3):351-60. PubMed ID: 19122447
[TBL] [Abstract][Full Text] [Related]
14. Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning.
Carvajal CC; Vercauteren F; Dumont Y; Michalkiewicz M; Quirion R
Behav Brain Res; 2004 Aug; 153(2):471-80. PubMed ID: 15265645
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional changes in water-maze learning following recombinant adenovirus-associated viral vector (rAAV)-mediated brain-derived neurotrophic factor expression in the rat hippocampus.
Pietropaolo S; Paterna JC; Büeler H; Feldon J; Yee BK
Behav Pharmacol; 2007 Sep; 18(5-6):533-47. PubMed ID: 17762522
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
19. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
20. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
Karlsson RM; Choe JS; Cameron HA; Thorsell A; Crawley JN; Holmes A; Heilig M
Psychopharmacology (Berl); 2008 Jan; 195(4):547-57. PubMed ID: 17891380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
